Bruker Retained Earnings (Accumulated Deficit) 2010-2025 | BRKR
Bruker retained earnings (accumulated deficit) from 2010 to 2025. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
- Bruker retained earnings (accumulated deficit) for the quarter ending March 31, 2025 were $2.416B, a 2.07% increase year-over-year.
- Bruker retained earnings (accumulated deficit) for 2024 were $2.407B, a 3.57% increase from 2023.
- Bruker retained earnings (accumulated deficit) for 2023 were $2.324B, a 20.65% increase from 2022.
- Bruker retained earnings (accumulated deficit) for 2022 were $1.926B, a 16.06% increase from 2021.
Bruker Annual Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2024 |
$2,407 |
| 2023 |
$2,324 |
| 2022 |
$1,926 |
| 2021 |
$1,660 |
| 2020 |
$1,407 |
| 2019 |
$1,275 |
| 2018 |
$1,103 |
| 2017 |
$942 |
| 2016 |
$885 |
| 2015 |
$757 |
| 2014 |
$656 |
| 2013 |
$599 |
| 2012 |
$519 |
| 2011 |
$442 |
| 2010 |
$349 |
| 2009 |
$254 |
Bruker Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $) |
| 2025-03-31 |
$2,416 |
| 2024-12-31 |
$2,407 |
| 2024-09-30 |
$2,401 |
| 2024-06-30 |
$2,367 |
| 2024-03-31 |
$2,367 |
| 2023-12-31 |
$2,324 |
| 2023-09-30 |
|
| 2023-06-30 |
|
| 2023-03-31 |
|
| 2022-12-31 |
$1,926 |
| 2022-09-30 |
|
| 2022-06-30 |
|
| 2022-03-31 |
|
| 2021-12-31 |
$1,660 |
| 2021-09-30 |
|
| 2021-06-30 |
|
| 2021-03-31 |
|
| 2020-12-31 |
$1,407 |
| 2020-09-30 |
|
| 2020-06-30 |
|
| 2020-03-31 |
|
| 2019-12-31 |
$1,275 |
| 2019-09-30 |
|
| 2019-06-30 |
|
| 2019-03-31 |
|
| 2018-12-31 |
$1,103 |
| 2018-09-30 |
|
| 2018-06-30 |
|
| 2018-03-31 |
|
| 2017-12-31 |
$942 |
| 2017-09-30 |
|
| 2017-06-30 |
|
| 2017-03-31 |
|
| 2016-12-31 |
$885 |
| 2016-09-30 |
|
| 2016-06-30 |
|
| 2016-03-31 |
|
| 2015-12-31 |
$757 |
| 2015-09-30 |
|
| 2015-06-30 |
|
| 2015-03-31 |
|
| 2014-12-31 |
$656 |
| 2014-09-30 |
|
| 2014-06-30 |
|
| 2014-03-31 |
|
| 2013-12-31 |
$599 |
| 2013-09-30 |
|
| 2013-06-30 |
|
| 2013-03-31 |
|
| 2012-12-31 |
$519 |
| 2012-09-30 |
$506 |
| 2012-06-30 |
$467 |
| 2012-03-31 |
|
| 2011-12-31 |
$442 |
| 2011-09-30 |
|
| 2011-06-30 |
|
| 2011-03-31 |
|
| 2010-12-31 |
$349 |
| 2010-09-30 |
|
| 2010-06-30 |
|
| 2010-03-31 |
|
| 2009-12-31 |
$254 |
| 2009-09-30 |
|
| 2009-06-30 |
|
| 2009-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$6.145B |
$3.366B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
